Zobrazeno 1 - 10
of 142
pro vyhledávání: '"J. Mitton"'
Publikováno v:
SynOpen, Vol 06, Iss 02, Pp 110-131 (2022)
The synthesis of aromatic heterocycles has attracted substantial attention due to the abundance of these heterocycles in drug molecules, natural products, and other compounds of biological interest. Accordingly, there is a demand for straightforward
Externí odkaz:
https://doaj.org/article/fe192d89bff14a64b7b754f4d163607a
Autor:
Anna Chen, Sheri Dellos-Nolan, Yanran Lu, Jason S. West, Daniel J. Wozniak, Mark J. Mitton-Fry
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 6 (2022)
ABSTRACT The development of novel treatments for Staphylococcus aureus infections remains a high priority worldwide. We previously reported compounds 0147 and 0186, novel bacterial topoisomerase inhibitors (NBTIs) with potent antibacterial activity a
Externí odkaz:
https://doaj.org/article/d5af706ff5d24891bc199c195e179153
Publikováno v:
Otology & Neurotology. 44:e328-e332
Autor:
Tanner J. Mitton, Kristen L. Yancey, Brandon Isaacson, Walter Kutz, Johanna Whitson, Jacob B. Hunter
Publikováno v:
Otolaryngology–Head and Neck Surgery. 168:1156-1163
Publikováno v:
Academic Medicine. 98:448-454
Concerns regarding interview hoarding in the Match process have led to calls for a cap on the number of interviews an applicant can accept. However, no study has examined the effects of interview caps on applicants or a specialty. The authors created
Autor:
Yanran Lu, Chelsea A. Mann, Sheri Nolan, Jessica A. Collins, Elizabeth Parker, Jonathan Papa, Sandip Vibhute, Seyedehameneh Jahanbakhsh, Mary Thwaites, David Hufnagel, Manzour H. Hazbón, Jane Moreno, Timothy T. Stedman, Thomas Wittum, Daniel J. Wozniak, Neil Osheroff, Jack C. Yalowich, Mark J. Mitton-Fry
Publikováno v:
ACS Med Chem Lett
[Image: see text] Antibacterial resistance continues its devastation of available therapies. Novel bacterial topoisomerase inhibitors (NBTIs) offer one solution to this critical issue. Two series of amine NBTIs bearing tricyclic DNA-binding moieties
Autor:
Linsen Li, Steffen Lindert, Yanran Lu, Anna Chen, Jason E. Cummings, Chelsea A Mann, Sandip Vibhute, Brieanna Roth, Anthony English, Sheri Nolan, Mark J. Mitton-Fry, Daniel J. Wozniak, Steven C Ratigan, Richard A. Slayden, Jack C. Yalowich, Bryan Koci, Antony A. Okumu, Jonathan L. Papa, Craig A. McElroy, Justin T Seffernick, Leonard R Duncan
Publikováno v:
Journal of Medicinal Chemistry. 64:15214-15249
Novel bacterial topoisomerase inhibitors (NBTIs) are among the most promising new antibiotics in preclinical/clinical development. We previously reported dioxane-linked NBTIs with potent antistaphylococcal activity and reduced hERG inhibition, a key
Autor:
Tanner J. Mitton, Daniel E. Killeen, Zoha K. Momin, Jacob B. Hunter, Brandon Isaacson, Kenneth Lee, Joe Walter Kutz
Publikováno v:
Otologyneurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 43(10)
To compare closure rates and hearing outcomes of microscopic and endoscopic tympanoplasty in pediatric patients.Retrospective chart review.Tertiary university medical center.Pediatric patients who underwent tympanoplasty surgery by a fellowship-train
Autor:
Josh Powell, Justin T Seffernick, Jonathan L. Papa, Daniel J. Wozniak, Jack C. Yalowich, Sheri Nolan, Mark J. Mitton-Fry, Yanran Lu, Nicholas Shkolnikov, Steffen Lindert, Anthony English
Publikováno v:
ACS Medicinal Chemistry Letters. 11:2446-2454
In recent years, novel bacterial topoisomerase inhibitors (NBTIs) have been developed as future antibacterials for treating multidrug-resistant bacterial infections. A series of dioxane-linked NBTIs with an amide moiety has been synthesized and evalu
Autor:
Yanran, Lu, Sandip, Vibhute, Linsen, Li, Antony, Okumu, Steven C, Ratigan, Sheri, Nolan, Jonathan L, Papa, Chelsea A, Mann, Anthony, English, Anna, Chen, Justin T, Seffernick, Bryan, Koci, Leonard R, Duncan, Brieanna, Roth, Jason E, Cummings, Richard A, Slayden, Steffen, Lindert, Craig A, McElroy, Daniel J, Wozniak, Jack, Yalowich, Mark J, Mitton-Fry
Publikováno v:
Journal of medicinal chemistry. 64(20)
Novel bacterial topoisomerase inhibitors (NBTIs) are among the most promising new antibiotics in preclinical/clinical development. We previously reported dioxane-linked NBTIs with potent antistaphylococcal activity and reduced hERG inhibition, a key